Physician

Kailash Mosalpuria, M.D., MPH

According to 2025 Medicare claims, Kailash Mosalpuria, M.D., MPH (NPI: 1669636643) practices medical oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is NEBRASKA HEMATOLOGY-ONCOLOGY, PC (NPI: 1205915071; TIN: 911806105) and primary practice location at 68506-7548. Mosalpuria is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Prairie Vista Care Organization (ACO ID: A3578), and Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Mosalpuria's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 865 traditional Medicare patients, billed 342,878 HCPCS/CPT codes, and received $6,406,112 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,496 prescription claims across 245 beneficiaries totaling $7,172,362 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2023 DME data shows 37 claims. Open Payments data shows 57 records totaling $995,146. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $229,156 to $6,406,112. Similarly, Part D prescription costs have moved sharply higher in recent years, from $863 to $7,172,362. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.2M$6.4M2016 Medicare payment: $229,156 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,363,721 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,979,028 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,396,916 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,713,139 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,960,453 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,939,848 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,945,009 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,406,112 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201619518,869$229,156
201749079,826$1,363,721
2018528119,916$1,979,028
2019592181,059$2,396,916
2020516125,113$1,713,139
2021706174,403$2,960,453
2022821214,988$3,939,848
2023789274,857$4,945,009
2024865342,878$6,406,112

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.6M$7.2M2015 Drug cost: $863 (USD; Tot_Drug_Cst)2016 Drug cost: $81,696 (USD; Tot_Drug_Cst)2017 Drug cost: $487,975 (USD; Tot_Drug_Cst)2018 Drug cost: $1,606,356 (USD; Tot_Drug_Cst)2019 Drug cost: $1,713,124 (USD; Tot_Drug_Cst)2020 Drug cost: $2,195,561 (USD; Tot_Drug_Cst)2021 Drug cost: $2,822,832 (USD; Tot_Drug_Cst)2022 Drug cost: $4,844,120 (USD; Tot_Drug_Cst)2023 Drug cost: $5,733,014 (USD; Tot_Drug_Cst)2024 Drug cost: $7,172,362 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R15$863
20162985$81,696
201781365$487,975
2018113748$1,606,356
2019114840$1,713,124
2020135966$2,195,561
20211981,251$2,822,832
20221961,225$4,844,120
20232061,157$5,733,014
20242451,496$7,172,362

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.0K$10K2018 Medicare payment: $10,061 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,893 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,916 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R61$10,061
2019N/RN/RN/R
2020N/R23$1,893
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R37$1,916
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more432860$86
80053Blood test, comprehensive group of blood chemicals6541,678$10
36415Insertion of needle into vein for collection of blood sample5871,497$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6772,301$8
83615Lactate dehydrogenase (enzyme) level5311,198$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate882,640$1,468,269
PomalystPomalidomide531,449$1,002,103
LenalidomideLenalidomide731,988$912,704
CalquenceAcalabrutinib Maleate531,590$782,690
RevlimidLenalidomide381,120$605,666

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$480ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.24$994,666Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kailash Mosalpuria, M.D., MPH?

Tedicare shows public-source Medicare data for Kailash Mosalpuria, M.D., MPH (NPI 1669636643), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kailash Mosalpuria, M.D., MPH have ACO affiliation data?

Kailash Mosalpuria, M.D., MPH is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Prairie Vista Care Organization (MSSP, ACO ID A3578), and Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Kailash Mosalpuria, M.D., MPH?

Kailash Mosalpuria, M.D., MPH is linked to NEBRASKA HEMATOLOGY-ONCOLOGY, PC (billing NPI 1205915071) in the available physician profile data.

Does Kailash Mosalpuria, M.D., MPH have Open Payments data?

Kailash Mosalpuria, M.D., MPH has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.